Outsourcing Pharma

AUGUST 28, 2023

CDMO, Sirio Europe, is launching two new softgels aimed at those who want to develop in the pharmaceutical consumer health space at this yearâs CPHI in Barcelona.

Development 82

Development Regulation Marketing 82

Pharmaceutical Technology

JUNE 30, 2023

Novartis has entered an agreement to divest its ophthalmology assets to eye health firm Bausch + Lomb in a deal valued at $2.5bn.

130

130

BioTech 365

JANUARY 18, 2021

LTC ACO and Third Eye Health Offer Virtual Care Network to Long-Term Care Patients, Facilities and Provider Groups LTC ACO and Third Eye Health Offer Virtual Care Network to Long-Term Care Patients, Facilities and Provider Groups Innovative Virtual Care Network … Continue reading →

40

40

XTalks

MARCH 13, 2024

This year’s week-long campaign is a platform for eye care professionals, health organizations and the medical device and healthcare industry to share the latest knowledge and innovations being explored and tested in the fight against glaucoma. million by 2040.

Gene Therapy 111

Gene Therapy Gene Life Science DNA 111

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 9, 2022

It can also bring about an increase in pollen levels, prolong the duration of pollen season, and cause more pollen-related health problems. Pollen grains landing on the moist membranes of the nose or eyes cause “hay fever” (allergic rhinitis) in one in five people. This often […].

Clinical Trials 187

Clinical Trials Clinical Trials Clinical Research Trials 187

Outsourcing Pharma

AUGUST 28, 2023

CDMO, Sirio Europe, is launching two new softgels aimed at those who want to develop in the pharmaceutical consumer health space at this yearâs CPHI in Barcelona.

Development 52

Development Regulation Marketing 52

BioTech 365

JULY 26, 2021

Santen and IAPB Taking Action to Implement the First Ever UN General Assembly Resolution Recognizing the Link Between Eye Health and Sustainable Development Santen and IAPB Taking Action to Implement the First Ever UN General Assembly Resolution Recognizing the Link … Continue reading →

Development 52

Development 52

Fierce Pharma

JUNE 30, 2023

Novartis is passing off the dry eye disease drop Xiidra to eye health specialist Bausch + Lomb in a $2.5 billion deal, another step in the company's overhaul as it focuses on five core areas. | Novartis is passing off the dry eye disease drop Xiidra to eye health specialist Bausch + Lomb in a $2.5

81

81

XTalks

SEPTEMBER 19, 2023

The US Food and Drug Administration (FDA) has issued warning letters to eight companies manufacturing or marketing unapproved eye products that violate federal law. Companies that the FDA sent the letters to include Walgreens, CVS Health, DR Vitamin Solutions, Natural Ophthalmics Inc.,

Production 105

Production Pharmacy Sales Drugs 105

NPR Health - Shots

FEBRUARY 16, 2023

Eye-opening testimony from a top scientist offers a useful primer on the role social media may play in the teen mental health crisis. Image credit: Tracy J. Lee for NPR)

Scientist 138

Scientist 138

Medical Xpress

JANUARY 4, 2023

An elderly woman struggles into a community health clinic in rural Texas amid a record-breaking heat wave. She's having a severe asthma attack, wheezing and gasping for air. As medical staff rush over the lights and air conditioning shut down due to an overtaxed power grid.

67

67

Pharma Times

APRIL 20, 2022

‘The Eyes Have It’ partnership will highlight the importance of eye health

140

140

STAT News

FEBRUARY 2, 2023

health officials are advising people to stop using over-the-counter eye drops that have been linked to an outbreak of drug-resistant infections. The Centers for Disease Control and Prevention on Wednesday night sent a health alert to physicians, saying the outbreak includes at least 55 people in 12 states. NEW YORK — U.S.

Bacteria 126

Bacteria Drugs 126

Fierce Pharma

SEPTEMBER 12, 2023

Eight companies are finding themselves in hot water for allegedly churning out illicit eye drugs, the FDA said Tuesday. | The companies included in the warning letter sweep are: Boiron, CVS Health, DR Vitamin Solutions, Natural Ophthalmics, OcluMed, Similasan, TRP Company and Walgreens Boots Alliance.

Drugs 92

Drugs 92

Fierce Pharma

FEBRUARY 21, 2024

Top buyout firms, including Advent International and Blackstone, have their eye on Sanofi's consumer health business, according to the news service. As Sanofi continues to plot its planned separation from its consumer healthcare division, the business has reportedly attracted interest from multiple private equity firms. |

73

73

Pharmaceutical Technology

MAY 30, 2023

Vabysmo is administered into the eye to treat patients with neovascular (wet) age-related macular degeneration (AMD) and diabetic macular oedema (DME). Roche Canada has successfully concluded talks with the pan-Canadian Pharmaceutical Alliance (pCPA) for Vabysmo (faricimab injection).

Antibody 130

Antibody Drugs Research 130

Medical Xpress

MARCH 21, 2023

Young children with autism spectrum disorder (ASD) are much less likely to receive vision screening than their peers, despite high risk for serious eye disorders, according to a study by Nemours Children's Health published today in Pediatrics.

98

98

BioSpace

AUGUST 29, 2021

is causing public health experts worldwide to keep an eye out for its presence as it seems to be more infectious and even more resistant to vaccines than other variants. A new variant, C.1.2.

Vaccination 144

Vaccination Vaccine 144

Pharma Times

MARCH 28, 2022

Digital health boost as new website focuses on dry eye disease, which currently affects one in four people across the UK

120

120

Rethinking Clinical Trials

JUNE 26, 2023

Pérez-Stable, MD This year’s annual Steering Committee meeting for the NIH Pragmatic Trials Collaboratory featured health equity as a central topic of discussion. Finally, Pérez-Stable cautioned that researchers must keep an eye on factors such as the digital divide so health disparities do not get exacerbated.

Research 130

Research Big Data Clinical Research Trials 130

Pharmaceutical Technology

AUGUST 4, 2022

Examples abound already in diabetes management, but smart monitoring and targeted interventions are also making inroads into the management of autoimmune disorders like inflammatory bowel disease, cardiovascular health issues, and cancer – both in monitoring the progression of those conditions, and in predicting and averting the chance of flare-ups.

Pharma Companies 358

Pharma Companies Branding Production Development 358

Medical Xpress

APRIL 4, 2023

However, reading can also compromise our visual health. Children and adolescents spend many hours reading at a developmental stage when their eyes are adjusting their growth based on visual input. Reading plays an important role in our society and is a fundamental component of our education system.

94

94

Scienmag

MARCH 7, 2022

Kyoto, Japan — Health issues for people over sixty commonly involve the heart and other vital organs. So do eye-related conditions such as cataracts and glaucoma, but dry eyes don’t often come to mind. Or do they?

84

84

Fierce Pharma

OCTOBER 2, 2023

As Viatris looks to reestablish itself as a focused eye care company, the company is slimming down by shedding its over-the-counter, women’s healthcare and active pharmaceutical ingredient business | After reaching deals with various buyers, Viatris is pulling out of women's health and selling most of its over-the-counter products.

Production 81

Production 81

Pharmaceutical Technology

MAY 10, 2023

Alvotech chairman and CEO Robert Wessman stated: “It is a pleasure to join forces with Polifarma in the commercialisation of a potential therapy in eye disease. “We The trial has been designed to assess the efficacy, safety and immunogenicity of the therapy combination in the targeted patients.

Trials 130

Trials Marketing Production Development 130

World of DTC Marketing

MARCH 29, 2022

A study has found that people with type 2 diabetes were at higher risk of developing 57 health conditions than non-diabetics. Proper diet and exercise seem to be the prescription for many common health problems: high blood pressure and cholesterol, heart disease, stroke, and obesity. This is not normal. What is the role of healthcare?

Development 231

Development Clinical Trials Clinical Trials Trials 231

BioPharma Reporter

NOVEMBER 20, 2023

At last monthâs CPHI Barcelona, Sirio launched its new ready-to-market menopause and eye health softgels in a bid to collaborate with over the counter (OTC) brands and large pharmacy chains looking to advance to market faster.

Pharmacy 52

Pharmacy Branding Marketing Development 52

Scienmag

JULY 12, 2022

Children with the eye cancer retinoblastoma in a low-income country are at 16 times higher risk of dying at any time within three years of diagnosis than those in high-income countries, according to a new study published in The Lancet Global Health.

Research 66

Research 66

Medical Xpress

FEBRUARY 24, 2023

UVA Health scientists have discovered an unknown contributor to harmful blood vessel growth in the eye that could lead to new treatments for blinding macular degeneration and other common causes of vision loss.

Scientist 75

Scientist Research 75

Scienmag

DECEMBER 9, 2021

Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease. Researchers from the National Eye Institute (NEI), part of the National Institutes of Health generated a “disease-in-a-dish” model to study the disease.

Gene 94

Gene Gene Therapy Scientist Drugs 94

STAT News

MARCH 24, 2023

— Herman Quintero was cracking jokes about the lottery, touching just below his right eye for luck. After two years helping him navigate his health care online, she was used to Quintero’s quips. It came down to the Mega Millions to pay the medical bill he pulled up on the Patient Gateway app on his phone.

105

105

Medical Xpress

FEBRUARY 21, 2023

Tweets by people in the public eye likely increasingly shaped negative public opinion of the COVID-19 pandemic as it progressed in the US, suggests an analysis of sentiments expressed in social media posts, published in the open access journal BMJ Health & Care Informatics.

75

75

Trialfacts

OCTOBER 12, 2023

Qualified health professionals will monitor your health as it relates to the study. If eligible, you and your child will return on another day to be fitted with MiSight 1-day contact lenses in one eye and ACUVUE OASYS for Presbyopia contact lenses in the other eye. Who Can Participate?

Research 52

Research Allergies Development 52

Medical Xpress

DECEMBER 6, 2022

Researchers with the Rutgers Environmental and Occupational Health Sciences Institute have simulated how climate change will affect the distribution of two leading allergens—oak and ragweed pollens—across the contiguous United States. The results, published in the journal Frontiers in Allergy, may make your eyes water.

Allergies 75

Allergies Research 75

STAT News

NOVEMBER 28, 2022

“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health. That is, until one day, walking to class, she lost vision in one eye. she had always been active and healthy. Read the rest…

98

98

Scienmag

JULY 6, 2022

The eye’s light-sensing retina taps different circuits depending on whether it is generating image-forming vision or carrying out a non-vision function such as regulating pupil size or sleep/wake cycles, according to a new mouse study from the National Eye Institute (NEI) and the National Institute of Mental Health (NIMH).

Research 84

Research Regulation 84

Scienmag

DECEMBER 11, 2020

recognized by Sanford and Susan Greenberg Prize to End Blindness Credit: OHSU/John Valls An ophthalmologist and researcher at Oregon Health & Science University Casey Eye Institute is being honored for co-inventing an eye imaging technology that is widely used to diagnose and guide treatment for people with the leading causes of […].

Research 86

Research Scientist Engineer Development 86